W. X. Zhou, “Strong Signals of Adverse Events in Tyrosine Kinase Inhibitor Therapy for Liver Cancer Treatment”, World J Oncol, vol. 17, no. 2, pp. 223–236, Jan. 2026, doi: 10.14740/wjon2685.